Genedx Holdings [WGS] vs Thermo Fisher [TMO] Detailed Stock Comparison

Genedx Holdings

NASDAQ
Loading...

Thermo Fisher

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Genedx Holdings wins in 4 metrics, Thermo Fisher wins in 15 metrics, with 0 ties. Thermo Fisher appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGenedx HoldingsThermo FisherBetter
P/E Ratio (TTM)1,478.2531.46Thermo Fisher
Price-to-Book Ratio12.254.06Thermo Fisher
Debt-to-Equity Ratio41.2769.62Genedx Holdings
PEG Ratio-10.995.54Genedx Holdings
EV/EBITDA114.1121.64Thermo Fisher
Profit Margin (TTM)0.39%15.24%Thermo Fisher
Operating Margin (TTM)8.73%17.84%Thermo Fisher
EBITDA Margin (TTM)8.73%17.84%Thermo Fisher
Return on Equity0.60%13.42%Thermo Fisher
Return on Assets (TTM)1.05%4.97%Thermo Fisher
Free Cash Flow (TTM)$-33.99M$7.27BThermo Fisher
Dividend YieldN/A0.31%N/A
1-Year Return137.37%-9.24%Genedx Holdings
Price-to-Sales Ratio (TTM)9.384.75Thermo Fisher
Enterprise Value$3.38B$234.09BThermo Fisher
EV/Revenue Ratio9.325.42Thermo Fisher
Gross Profit Margin (TTM)69.04%40.61%Genedx Holdings
Revenue per Share (TTM)$13$114Thermo Fisher
Earnings per Share (Diluted)$0.08$17.27Thermo Fisher
Beta (Stock Volatility)2.040.78Thermo Fisher
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Genedx Holdings vs Thermo Fisher Stock Performance Analysis

Loading Price Chart...

Genedx Holdings
Thermo Fisher
Genedx Holdings Stock Overview | Thermo Fisher Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Genedx Holdings0.76%0.90%-7.04%29.09%47.62%48.51%
Thermo Fisher3.50%17.03%12.13%26.55%15.59%3.97%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Genedx Holdings137.37%302.66%1,106.73%1,106.73%1,106.73%1,106.73%
Thermo Fisher-9.24%3.76%16.92%329.43%1,044.80%1,683.13%

News Based Sentiment: Genedx Holdings vs Thermo Fisher

Genedx Holdings

News based Sentiment: MIXED

October presented a mixed bag for GeneDx, with a significant earnings beat and the launch of a major NIH-funded initiative offset by a downgrade from Zacks and a premium valuation. While the positive developments are encouraging, the mixed signals suggest a cautious approach is warranted.

View Genedx Holdings News Sentiment Analysis

Thermo Fisher

News based Sentiment: POSITIVE

Thermo Fisher Scientific demonstrated a strong month with strategic acquisitions (Solventum's purification business for $4.1 billion and Sanofi's sterile fill-finish site), innovative product launches, and positive financial results exceeding expectations in Q2 2025. This, combined with optimistic guidance, signals a positive trajectory for the company and strengthens the investment case.

View Thermo Fisher News Sentiment Analysis

Performance & Financial Health Analysis: Genedx Holdings vs Thermo Fisher

MetricWGSTMO
Market Information
Market Cap i$3.51B$206.14B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i518,5203,290,780
90 Day Avg. Volume i532,3232,194,303
Last Close$118.26$543.32
52 Week Range$44.16 - $136.00$385.46 - $611.49
% from 52W High-13.04%-11.15%
All-Time High$417.42 (Aug 09, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-71.67%-19.19%
Growth Metrics
Quarterly Revenue Growth0.46%0.03%
Quarterly Earnings Growth0.46%0.05%
Financial Health
Profit Margin (TTM) i0.00%0.15%
Operating Margin (TTM) i0.09%0.18%
Return on Equity (TTM) i0.01%0.13%
Debt to Equity (MRQ) i41.2769.62
Cash & Liquidity
Book Value per Share (MRQ)$9.65$133.77
Cash per Share (MRQ)$4.68$16.92
Operating Cash Flow (TTM) i$13.02M$7.58B
Levered Free Cash Flow (TTM) i$20.21M$5.18B
Dividends
Last 12-Month Dividend Yield iN/A0.31%
Last 12-Month Dividend iN/A$1.21

Valuation & Enterprise Metrics Analysis: Genedx Holdings vs Thermo Fisher

MetricWGSTMO
Price Ratios
P/E Ratio (TTM) i1,478.2531.46
Forward P/E i241.3523.13
PEG Ratio i-10.995.54
Price to Sales (TTM) i9.384.75
Price to Book (MRQ) i12.254.06
Market Capitalization
Market Capitalization i$3.51B$206.14B
Enterprise Value i$3.38B$234.09B
Enterprise Value Metrics
Enterprise to Revenue i9.325.42
Enterprise to EBITDA i114.1121.64
Risk & Other Metrics
Beta i2.040.78
Book Value per Share (MRQ) i$9.65$133.77

Financial Statements Comparison: Genedx Holdings vs Thermo Fisher

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)WGSTMO
Revenue/Sales i$102.69M$10.36B
Cost of Goods Sold i$31.79M$6.13B
Gross Profit i$70.90M$4.24B
Research & Development i$14.87M$342.00M
Operating Income (EBIT) i$8.96M$1.82B
EBITDA i$15.39M$2.73B
Pre-Tax Income i$10.56M$1.62B
Income Tax i$-246,000$95.00M
Net Income (Profit) i$10.81M$1.51B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)WGSTMO
Cash & Equivalents i$99.70M$4.13B
Total Current Assets i$225.82M$23.38B
Total Current Liabilities i$69.54M$13.17B
Long-Term Debt i$111.71M$31.37B
Total Shareholders Equity i$257.41M$49.49B
Retained Earnings i$-1.36B$54.45B
Property, Plant & Equipment i$51.39MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)WGSTMO
Operating Cash Flow i$-1.74M$2.15B
Capital Expenditures i$-6.13M$-350.00M
Free Cash Flow i$4.05M$361.00M
Debt Repayment i$-911,000$-838.00M
Common Stock Repurchase iN/A$-2.00B

Short Interest & Institutional Ownership Analysis

MetricWGSTMO
Shares Short i3.61M3.83M
Short Ratio i6.002.34
Short % of Float i0.25%0.01%
Average Daily Volume (10 Day) i518,5203,290,780
Average Daily Volume (90 Day) i532,3232,194,303
Shares Outstanding i28.02M380.77M
Float Shares i20.45M376.74M
% Held by Insiders i0.12%0.00%
% Held by Institutions i1.11%0.92%

Dividend Analysis & Yield Comparison: Genedx Holdings vs Thermo Fisher

MetricWGSTMO
Last 12-Month Dividend iN/A$1.21
Last 12-Month Dividend Yield iN/A0.31%
3-Year Avg Annual Dividend iN/A$1.33
3-Year Avg Dividend Yield iN/A0.07%
3-Year Total Dividends iN/A$3.99
Ex-Dividend DateN/AMar 14, 2025